StatOrigin open statistical archive
Industries Indicators Regions Rankings Compare Sources

IFRS net income

Net profit or loss for the period attributable to equity holders under International Financial Reporting Standards.

Unit million EUR Industry Pharmaceuticals

Cite & reuse Get this data as JSON
Records
2
Regions
1
Period
2026
Sources
1
Verification 2 verified data points Verified 15 Sep 2026 Next update Sources typically refresh quarterly

The chart

Over time

Global over time. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.

IFRS net income

Global, Q1 2026 to Q2 2026

2 observations · Q1 2026 to Q2 2026
IFRS net incomeIFRS net income. 2 observations from Q1 2026 to Q2 2026, ranging from 343 million EUR to 1,957 million EUR. Latest value 343 million EUR (Q2 2026). million EUR 0 500 1,000 1,500 2,000 8 Jan 15 Jan 22 Jan 5 Feb 15 Feb 22 Feb 8 Mar 15 Mar 22 Mar 29 Mar 2026 Feb 2026 Mar 2026 1,957 343
IFRS net incomeIFRS net income. 2 observations from Q1 2026 to Q2 2026, ranging from 343 million EUR to 1,957 million EUR. Latest value 343 million EUR (Q2 2026). million EUR 0 500 1,000 1,500 2,000 8 Jan 15 Jan 22 Jan 8 Feb 15 Feb 22 Feb 8 Mar 15 Mar 22 Mar 29 Mar 2026 Feb 2026 Mar 2026 1,957 343
IFRS net incomeIFRS net income. 2 observations from Q1 2026 to Q2 2026, ranging from 343 million EUR to 1,957 million EUR. Latest value 343 million EUR (Q2 2026). million EUR 0 500 1,000 1,500 2,000 8 Jan 22 Mar Feb 2026 Mar 2026 1,957 343
View the underlying data
IFRS net income
Period Type Value
Q1 2026 Actual 1,957 million EUR
Q2 2026 Actual 343 million EUR
Source: Sanofi · CC BY 4.0 · statorigin.org
Embed

Free to embed, including commercially. The attribution bar is part of the chart; it is what keeps the data citable. 

<iframe src="https://statorigin.org/embed/pharmaceuticals--ifrs-net-income--trend" width="100%" height="380" style="border:1px solid #e2e5e3;border-radius:8px" title="IFRS net income" loading="lazy"></iframe>
<p><a href="https://statorigin.org/indicators/ifrs-net-income">IFRS net income</a> — data from StatOrigin, CC BY 4.0</p>
Preview embed

Every record

All records

2 records · 1 region · 2026

Download CSV JSON series
IFRS net income: every record, grouped by region, newest first.
Period Value Source Type
Global 2 records
Q2 2026 343 million EUR Sanofi · 30 Jul 2026 actual
Q1 2026 1,957 million EUR Sanofi · 30 Jul 2026 actual

Primary documents

Sources

1 document. Each links to the publisher's own copy.

Document Publisher Published Data points
Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded Sanofi 30 Jul 2026 2

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). IFRS net income. Retrieved from https://statorigin.org/indicators/ifrs-net-income

Download CSV Get this data as JSON Compare with… API docs